Citations (40)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
G. C. Kahn, M. Rubenfield, D. S. Davies & A. R. Boobis. (1987) Phenacetin O-deethylase activity of the rat: strain differences and the effects of enzyme-inducing compounds. Xenobiotica 17:2, pages 179-187.
Read now
Read now
S. I. Islam, J. R. Idle & R. L. Smith. (1980) The polymorphic 4-hydroxylation of debrisoquine in a Saudi arab population. Xenobiotica 10:11, pages 819-825.
Read now
Read now
C. Mbanefo, E. A. Bababunmi, A. Mahgoub, T. P. Sloan, J. R. Idle & R. L. Smith. (1980) A study of the debrisoquine hydroxylation polymorphism in a Nigerian population. Xenobiotica 10:11, pages 811-818.
Read now
Read now
Y. K. Seedat. (1980) An evaluation of debrisoquine and mefruside in the treatment of hypertension in African and Indian patients. Current Medical Research and Opinion 7:1, pages 68-72.
Read now
Read now
Articles from other publishers (36)
Ayushi Vaidhya, Kanika Ghildiyal, Divya Rajawat, Sonali Sonejita Nayak, Subhashree Parida & Manjit Panigrahi. (2023) Relevance of pharmacogenetics and pharmacogenomics in veterinary clinical practice: A review. Animal Genetics.
Crossref
Crossref
Ahmad A. Almeman. (2021) Major CYP450 Polymorphism among Saudi Patients. Drug Metabolism Letters 14:1, pages 17-24.
Crossref
Crossref
Adrián LLerena. 2005. Biology of Depression. Biology of Depression
879
902
.
A. R. Boobis, T. Shiga & R. J. Edwards. 2004. Cardiovascular Pharmacogenetics. Cardiovascular Pharmacogenetics
39
77
.
Takako Shimizu, Hirohide Ochiai, Fredrik Åsell, Hiroshi Shimizu, Ryuta Saitoh, Yoshimasa Hama, Jun Katada, Munehiro Hashimoto, Hitoshi Matsui, Katsuhiko Taki, Tsuguchika Kaminuma, Michiko Yamamoto, Yoshitaka Aida, Akira Ohashi & Naoki Ozawa. (2003) Bioinformatics Research on Inter-racial Difference in Drug Metabolism I. Analysis on Frequencies of Mutant Alleles and Poor Metabolizers on CYP2D6 and CYP2C19. Drug Metabolism and Pharmacokinetics 18:1, pages 48-70.
Crossref
Crossref
Poolsup, Li Wan Po & Knight. (2000) Pharmacogenetics and psychopharmacotherapy. Journal of Clinical Pharmacy and Therapeutics 25:3, pages 197-220.
Crossref
Crossref
Julia A Hasler, Ronald Estabrook, Michael Murray, Irina Pikuleva, Michael Waterman, Jorge Capdevila, Vijakumar Holla, Christian Helvig, John R Falck, Geoffrey Farrell, Laurence S Kaminsky, Simon D Spivack, Eric Boitier & Philippe Beaune. (1999) Human cytochromes P450. Molecular Aspects of Medicine 20:1-2, pages 1-137.
Crossref
Crossref
Collen M. Masimirembwa & Julia A. Hasler. (1997) Genetic Polymorphism of Drug Metabolising Enzymes in African Populations: Implications for the Use of Neuroleptics and Antidepressants. Brain Research Bulletin 44:5, pages 561-571.
Crossref
Crossref
Michael Smith & Keh-Ming Lin. 1996. Handbook of Diversity Issues in Health Psychology. Handbook of Diversity Issues in Health Psychology
389
406
.
S. Wanwimolruk, MR Thou & DJ Woods. (2012) Evidence for the polymorphic oxidation of debrisoquine and proguanil in a Khmer (Cambodian) population.. British Journal of Clinical Pharmacology 40:2, pages 166-169.
Crossref
Crossref
Robert J. Straka, Shawn R. Hansen & Patricia F. Walker. (1995) Comparison of the prevalence of the poor metabolizer phenotype for CYP2D6 between 203 Hmong subjects and 280 white subjects residing in Minnesota*. Clinical Pharmacology & Therapeutics 58:1, pages 29-34.
Crossref
Crossref
K. Orzechowska-Juzwenko, J. Pawlik, P. Niewiński, P. Milejski, J. Dembowski, J. Turek, A. Goździk, L. Swiebodzki & Z. Hora. (1994) Genetically determined sparteine oxidation polymorphism in a Polish population. European Journal of Clinical Pharmacology 46:5, pages 481-483.
Crossref
Crossref
E. Spina, G.M. Campo, A. Avenoso, A.P. Caputi, P. Zuccaro, R. Pacifici, G. Gatti, G. Strada, A. Bartoli & E. Perucca. (1994) CYP2D6-related oxidation polymorphism in Italy. Pharmacological Research 29:3, pages 281-289.
Crossref
Crossref
Y. M. Irshaid, H. F. Al-Hadidi & N. M. Rawashdeh. (1993) Dextromethorphan O-demethylation polymorphism in Jordanians. European Journal of Clinical Pharmacology 45:3, pages 271-273.
Crossref
Crossref
P. Lledó. (2012) Variations in Drug Metabolism Due to Genetic Polymorphism. Drug Investigation 5:1, pages 19-34.
Crossref
Crossref
A. K. Daly & J. R. Idle. 1993. Cytochrome P450. Cytochrome P450
433
446
.
M. E. Veronese & S. McLean. (1991) Debrisoquine oxidation polymorphism in a Tasmanian population. European Journal of Clinical Pharmacology 40:5, pages 529-532.
Crossref
Crossref
G. Boriarti, E. Strocchi, A. Capucci, S. Boschi, B. Marchesini, E. Ambrosioni & B. Magnani. (2012) Relationships Between Debrisoquine Hydroxylation and Propafenone Pharmacokinetics. Drug Investigation 2:2, pages 114-119.
Crossref
Crossref
S Wanwimolruk, P Patamasucon & EJ Lee. (2012) Evidence for the polymorphic oxidation of debrisoquine in the Thai population.. British Journal of Clinical Pharmacology 29:2, pages 244-247.
Crossref
Crossref
M. Eichelbaum & A.S. Gross. (1990) The genetic polymorphism of debrisoquine/sparteine metabolism — Clinical aspects. Pharmacology & Therapeutics 46:3, pages 377-394.
Crossref
Crossref
De K. Sommers, J. Moncrieff & J. Avenant. (2016) Polymorphism of the 4-Hydroxylation of Debrisoquine in the San Bushmen of Southern Africa. Human Toxicology 7:3, pages 273-276.
Crossref
Crossref
I. Roots, G. Heinemeyer, N. Drakoulis & D. Kampf. 1987. Epidemiological Concepts in Clinical Pharmacology. Epidemiological Concepts in Clinical Pharmacology
105
118
.
JA Critchley, GR Nimmo, CA Gregson, NM Woolhouse & LF Prescott. (1986) Inter-subject and ethnic differences in paracetamol metabolism.. British Journal of Clinical Pharmacology 22:6, pages 649-657.
Crossref
Crossref
Evelyne Jacqz, Stephen D. Hall & Robert A. Branch. (1986) Genetically determined polymorphisms in drug oxidation. Hepatology 6:5, pages 1020-1032.
Crossref
Crossref
W. Kalow. (1986) Genetics of drug transformation. Clinical Biochemistry 19:2, pages 76-82.
Crossref
Crossref
André Barbeau, Madeleine Roy, Suzanne Paris, Thérèse Cloutier, Lorraine Plasse & Judes Poirier. (1985) ECOGENETICS OF PARKINSON'S DISEASE: 4-HYDROXYLATION OF DEBRISOQUINE. The Lancet 326:8466, pages 1213-1216.
Crossref
Crossref
M Jurima, T Inaba, D Kadar & W Kalow. (2012) Genetic polymorphism of mephenytoin p(4′)‐hydroxylation: difference between Orientals and Caucasians.. British Journal of Clinical Pharmacology 19:4, pages 483-487.
Crossref
Crossref
M. Eichelbaum & N. M. Woolhouse. (1985) Inter-ethnic difference in sparteine oxidation among Ghanaians and Germans. European Journal of Clinical Pharmacology 28:1, pages 79-83.
Crossref
Crossref
Claus Hölzel & Gerhard Spiteller. (2006) Piperin – ein Beispiel für individuell unterschiedliche (polymorphe) Metabolisierung einer allgegenwärtigen Nahrungskomponente. Liebigs Annalen der Chemie 1984:7, pages 1319-1331.
Crossref
Crossref
D. M. Roden, T. Wang, R. L. Woosley, A. J. J. Wood, R. A. Branch, A. Küpfer & G. R. Wilkinson. 1984. Pharmacokinetics. Pharmacokinetics
217
234
.
Peter J. Meier, Heinz K. Mueller, Bernhard Dick & Urs A. Meyer. (1983) Hepatic monooxygenase activities in subjects with a genetic defect in drug oxidation. Gastroenterology 85:3, pages 682-692.
Crossref
Crossref
D. B. Jack. (1983) Statistical analysis of polymorphic drug metabolism data using the Rosin Rammler Sperling Weibull distribution. European Journal of Clinical Pharmacology 25:4, pages 443-448.
Crossref
Crossref
Adrian Küpfer, Sabah G. Al-Dabbagh, James C. Ritchie, Jeffrey R. Idle & Robert L. Smith. (1982) Spectral binding studies of the polymorphically metabolized drugs debrisoquine, sparteine and phenformin by cytochrome P-450 of normal and hydroxylation deficient rat strains. Biochemical Pharmacology 31:20, pages 3193-3199.
Crossref
Crossref
J.R. Idle, A. Mahgoub, T.P. Sloan, R.L. Smith, C.O. Mbanefo & E.A. Bababunmi. (1981) Some observations on the oxidation phenotype status of Nigerian patients presenting with cancer. Cancer Letters 11:4, pages 331-338.
Crossref
Crossref
Daniel B Menzel. (1980) Carcinogens and Other Toxic Hazards: How Accurate Are Animal Studies?. Pediatric Annals 9:12, pages 48-56.
Crossref
Crossref
A Bababunmi, JR Idle, A Mahgoub, C Mbanefo & RL Smith. (2012) Polymorphic hydroxylation of debrisoquine in Nigerians [proceedings]. British Journal of Clinical Pharmacology 9:1.
Crossref
Crossref